- Research works
- 35 ▼ 10% vs 2013–17
- Citations
- 1.1k 31.7 per fractional work
- Top-10% rate
- 14.4% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Nordic Society of Gynecologic Oncology is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.1×. Every wedge is a field page.
Which keywords describe research at Nordic Society of Gynecologic Oncology?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Biomarkers, Cytoreductive Surgery, Metastasis, Ovarian Cancer, Genomic Analysis and Mutation Analysis.
- Innovation
- Targeted Therapy
- Epidemiology
- Acute Myeloid Leukemia
- Immunotherapy
- Acute Lymphoblastic Leukemia
- Brachytherapy
- PARP Inhibitors
- Cervical Cancer
- BRCA Mutation
- Cancer Therapy
- Prognostic Factors
- Mutation Analysis
- Ovarian Cancer
- Cytoreductive Surgery
- Clinical Trials
- Chemotherapy
- Biomarkers
- Metastasis
- Genomic Analysis
- Tumor Models
- Survival Analysis
- Clinical Practice Guidelines
- Cell Death
- Homologous Recombination
- Synthetic Lethality
- Endometrial Carcinoma
- Childhood Cancer
- AML
- Hematopoietic Stem Cells
- Health-related Quality of Life
- Childhood Cancer Survivor Study
- Pediatric Quality of Life Inventory
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Chemotherapy6▲ 25×8 topics
- Clinical Trials6▲ 28×9 topics
- Biomarkers6▲ 27×4 topics
- Cytoreductive Surgery6▲ 249×2 topics
- Metastasis6▲ 46×5 topics
- Ovarian Cancer5▲ 165×3 topics
- Genomic Analysis5▲ 51×2 topics
- Mutation Analysis5▲ 197×1 topic
- Tumor Models5▲ 242×1 topic
- Prognostic Factors3▲ 20×7 topics
- Survival Analysis2▲ 26×3 topics
- Cancer Therapy2▲ 10×4 topics
- Clinical Practice Guidelines2▲ 11×4 topics
- BRCA Mutation2▲ 327×1 topic
- Cell Death2▲ 28×2 topics
- Cervical Cancer2▲ 58×2 topics
- Homologous Recombination2▲ 85×2 topics
- PARP Inhibitors2▲ 327×1 topic
- Synthetic Lethality2▲ 230×2 topics
- Brachytherapy2▲ 147×1 topic
- Endometrial Carcinoma2▲ 147×1 topic
- Acute Lymphoblastic Leukemia1▲ 107×1 topic
- Childhood Cancer1▲ 107×1 topic
- Immunotherapy1▲ 6.1×7 topics
- AML1▲ 76×1 topic
- Acute Myeloid Leukemia1▲ 76×1 topic
- Hematopoietic Stem Cells1▲ 36×2 topics
- Epidemiology1▼ 0.79×14 topics
- Health-related Quality of Life1▲ 15×2 topics
- Targeted Therapy1▲ 14×5 topics
- Childhood Cancer Survivor Study1▲ 69×1 topic
- Innovation1▲ 3.1×2 topics
- Pediatric Quality of Life Inventory1▲ 69×1 topic
Which research topics does Nordic Society of Gynecologic Oncology publish most on?
By volume in 2022–2025: Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy and Voice and Speech Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 2 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
- 3 PARP inhibition in cancer therapy Oncology 1 works
- 4 Voice and Speech Disorders Physiology 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Music Therapy and Health Social Psychology 0 works
- 7 Stuttering Research and Treatment Clinical Psychology 0 works
- 8 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 10 Smart Grid Energy Management Electrical and Electronic Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nordic Society of Gynecologic Oncology's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Copenhagen
- University of Copenhagen
- Rigshospitalet
- Copenhagen Business School
- Copenhagen University Hospital
- Gentofte Hospital
- Bispebjerg Hospital
- Statens Serum Institut
- Novo Nordisk (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.